DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Metro Brands Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 3d ago·27 Aug 2026, 12:53 pm

Metro Brands

Metro Brands Limited has announced its upcoming schedule for an analyst and institutional investor meeting. This event is a standard corporate practice where the company management meets with financial experts and large investors to discuss its business performance and future outlook.

For investors, such meetings are important because they provide a direct channel for the company to communicate its strategy and address market questions. It offers a chance for the firm to showcase its growth plans and operational efficiency to a broad audience of market participants.

Investors should watch for any updates regarding the company's expansion plans, sales trends, or margin commentary during the interaction. These insights can help gauge the management's confidence in the current business environment and future growth trajectory.